Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AddLife AB's gross profit for the
three
months ended in Jun. 2026 was $113 Mil. AddLife AB's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was $432 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. AddLife AB's gross profit for the
three
months ended in Jun. 2026 was $113 Mil. AddLife AB's Revenue for the
three
months ended in Jun. 2026 was $286 Mil. Therefore, AddLife AB's Gross Margin % for the quarter that ended in Jun. 2026 was 39.47%.
AddLife AB had a gross margin of 39.47% for the quarter that ended in Jun. 2026 => Competition eroding margins
During the past 13 years, the highestGross Margin % of AddLife AB was 38.43%. The lowest was 34.44%. And the median was 35.95%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
AddLife AB had a gross margin of 39.47% for the quarter that ended in Jun. 2026 => Competition eroding margins
AddLife AB Gross Profit Related Terms
AddLife AB Gross Profit Historical Data
* Premium members only.
The historical data trend for AddLife AB's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AddLife AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Gross Profit distribution charts can be found below:
* The bar in red indicates where AddLife AB's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $432 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
AddLife AB (ADDLF) has a Gross Profit of $432 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on AddLife AB and its competitors.
Is AddLife AB's Gross Profit too high?
AddLife AB's current Gross Profit is $432 Mil. Overall, AddLife AB has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does AddLife AB's Gross Profit compare to ISRG and BDX?
AddLife AB's Gross Profit of $432 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on AddLife AB and its competitors. AddLife AB's current Gross Profit is $432 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AddLife AB stock overvalued right now?
AddLife AB (ADDLF) has a current Gross Profit of $432 Mil. The stock's GF Value™ is $14.61, compared to a current price of $15.75 — trading 7.8% above its estimated fair value. The current Gross Profit is $432 Mil. AddLife AB's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For AddLife AB (ADDLF), the current Gross Profit is $432 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AddLife AB (ADDLF) Overvalued in 2026?
Based on GuruFocus' analysis, AddLife AB stock appears to be overvalued.
The current stock price of $15.75 is trading 7.8% above its estimated GF Value™ of $14.61.
Key valuation signals for ADDLF:
Gross Profit: $432 Mil
GF Value™: $14.61 vs. price of $15.75 (7.8% above fair value)
No single metric tells the full story. See the ADDLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech. The Labtech segment provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service to laboratories in medicine, research, academia and the food and pharmaceutical industries. The Medtech segment includes a range that spans from basic consumables to instruments for surgical procedures, welfare technology, and assistive devices for the elderly and disabled. The majority of revenue is derived from the Medtech segment.
80GF Score
Get the complete analysis for ADDLF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADDLF has been successfully added to your 
